Y. BEYAZIT Et Al. , "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305, 2010
BEYAZIT, Y. Et Al. 2010. Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2 , 304-305.
BEYAZIT, Y., KEKİLLİ, M., Kurt, M., Sayilir, A., Tas, A., & Onal, I. K., (2010). Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, 304-305.
BEYAZIT, YAVUZ Et Al. "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, 304-305, 2010
BEYAZIT, YAVUZ Et Al. "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305, 2010
BEYAZIT, Y. Et Al. (2010) . "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305.
@article{article, author={YAVUZ BEYAZIT Et Al. }, title={Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2010, pages={304-305} }